Status:
COMPLETED
Optimizing BCI-FIT: Brain Computer Interface - Functional Implementation Toolkit
Lead Sponsor:
Oregon Health and Science University
Conditions:
Amyotrophic Lateral Sclerosis
Brainstem Stroke
Eligibility:
All Genders
18-89 years
Phase:
NA
Brief Summary
This project adds to non-invasive BCIs for communication for adults with severe speech and physical impairments due to neurodegenerative diseases. Researchers will optimize \& adapt BCI signal acquisi...
Detailed Description
For each specific aim, the development of new assistive technology BCI access methods will be evaluated in one or more experiments using alternating-treatments single-case research design (SCRD) with ...
Eligibility Criteria
Inclusion
- Controls
- Able to read and communicate in English
- Capable of participating in study visits lasting 1-3 hours
- Adequate visuospatial skills to select letters, words, or icons to copy or generate messages
- Live within a 2-hour drive of OHSU or is willing to travel to OHSU
- Participants with severe speech and physical impairment:
- Adults between 18-89 years of age
- SSPI that may result from a variety of degenerative or neurodevelopmental conditions, including but not limited to: Duchenne muscular dystrophy, Rett Syndrome, ALS, brainstem CVA, SCI, and Parkinson-plus disorders (MSA, PSP)
- Able to read and communicate in English with speech or AAC device
- Capable of participating in study visits lasting 1-3 hours
- Adequate visuospatial skills to select letters, words or icons to copy or generate basic messages
- Life expectancy greater than 6 months
- Able to give informed consent or assent according to IRB approved policy
Exclusion
- Participants with severe speech and physical impairment:
- Unstable medical conditions (fluctuating health status resulting in multiple hospitalizations within a 6 week interval)
- Unable to tolerate weekly data collection visits
- Photosensitive seizure disorder
- Presence of implanted hydrocephalus shunt, cochlear implant or deep brain stimulator
- High risk of skin breakdown from contact with data acquisition hardware.
Key Trial Info
Start Date :
July 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 5 2025
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT04468919
Start Date
July 15 2022
End Date
May 5 2025
Last Update
May 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oregon Health & Science University
Portland, Oregon, United States, 97239